Mesothelioma.com Resources for Patients and their Families

Lufkin, Texas

Lufkin, a city in and the county seat of Angelina County, is situated in the heart of the Forest Country of East Texas. Founded in 1882 as a stop on the Houston, East and West Texas Railway, Lufkin was named for Captain Abraham P. Lufkin, a Galveston cotton merchant and city councilman. Lufkin's population reached nearly 33,000 in 2000 making it the 76th largest city in Texas. Despite is size, Lufkin remains quaint while serving as a regional hub for retail shopping, medical facilities, industry, and government.

Up until the 1930s, Lufkin's initial growth both economically and as a community was largely due to its proximity to the railroad and because of the timber boom in the surrounding area. During 1938 and 1945, a period often referred to as city's "golden era of expansion", industrial expansion produced thousands of new jobs and continued widespread community growth. Southland Paper Mills (now Abitibi) and Texas Foundries, both founded in the late 1930s, were two of the local companies responsible for much of the city's industrial growth. Another significant employer in Lufkin's history, was Lufkin Foundry and Machine Company (now Lufkin Industries). Lufkin Foundry was founded in 1902 to service the repair needs of the railroads and sawmills. The company would achieve worldwide acclaim for its oilfield pumping units. Though Lufkin's economy was still largely tied to the harvesting of timber and the manufacture of lumber, paper, plywood, and other forest products through the 1980s, by 1990 the city had developed a diversified economic base, including the manufacture of machinery and gears, truck trailers and flooring, foundry products, candy, dairy products, and recreational goods.

Lufkin, Texas has many sites where asbestos containing products were known to be used, particularly in the manufacturing and industrial settings. Workers exposed to asbestos may be at risk to develop mesothelioma, a type of asbestos-related cancer. If you were exposed asbestos in Lufkin and have been diagnosed with mesothelioma cancer, you should consider contacting a mesothelioma law firm.

Asbestos Exposure at Jobsites in Lufkin

The Mesothelioma Cancer Alliance has compiled information obtained from a number of sources to identify the following jobsites in Lufkin where asbestos exposure was known to have occurred. These sites are listed below.

  • Abitibi-Consolidated Corporation
  • Angelina Hardwood Plant
  • Brookhollow Elementary 1009 Live Oak Lane
  • Champion International Paper Mill
  • Champion Paper Company
  • Coston Elementary
  • Donohue Industries Inc
  • Donohue Paper Mill
  • Garrett Elementary
  • Georgia Pacific
  • Kurth Elementary
  • Lufkin Foundry
  • Lufkin Industries
  • Lufkin Paper Mill
  • Morris Boulger Destructors
  • Natural Gas Pipeline Company of America
  • Owens Illinois
  • Southland Paper Company
  • Southland Paper Mills Inc.
  • St. Regis Paper Mill
  • Standard Asbestos
  • Texas Foundries, Inc.

Filing an Asbestos Lawsuit in Lufkin, Texas

Don’t lose your rights! If you or a loved one has been diagnosed with mesothelioma and were exposed to asbestos in Texas, you may be entitled to compensation. You may have limited time to file a claim. If you have been diagnosed with mesothelioma and have a pathology report in hand to support that diagnosis, you are eligible for financial assistance.

Asbestos Related News in Texas

Dangerous Asbestos Levels In Devine, Texas’ Water

The city of Devine, Texas, has warned its residents that high levels of asbestos has been present in their drinking water for at a year or longer.

Phase II Trial for New Mesothelioma Treatment Opens to Patients

A Phase II clinical trial testing a new treatment for mesothelioma is now open to patients at Baylor College of Medicine Treatment Center.

Asbestos Exposure Across the U.S.

Mesothelioma Cancer Alliance Blog

FEATURED CONTENT:


RECENT POSTS:

Remembering Mesothelioma Victims in the UK

The Challenges of Research in Immunotherapy

The Importance of Cancer Research in Immunotherapy